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Basal cell carcinoma (BCC) is the most common tumour in Caucasians and is 
usually localized in sun-exposed body areas as face or trunk. The localization of 
BCC in genitalia is atypical, but we have to consider this diagnosis when we find 
a lesion in vulva. The most common vulvar malignancy is squamous cell 
carcinoma (SCC) that can develop from vulvar intraepithelial neoplasia (VIN) or 
de novo. (Chokoeva AA. Vulvar cancer: a review for dermatologists).  Vulvar 
BCCs are not related to human papillomavirus (HPV) infection as other 
tumours located in this area as SCC or VIN. In fact, the detection of HPV could 
be used to distinguish BCC from basaloid SCC. (Elwood H et al. Basal cell 
carcinomas of the vulva: high risk human papillomavirus DNA detection, p 16 
and BerEP4 expression. Am J Surg Pathol.). Women over 60 years are the main 
affected, chronic vulvar irritation could be a risk factor.  (Kara M et al. Vulvar 
basal cell carcinoma. Indian J Pathol Microbiol.). 
Patients usually consult because they present itch or bleed in the vulva and in 
the moment of the examination we find a tumour as the cause of their 
symptoms.   The clinical image and prognosis of vulvar BCC are quite different 
from others BCC such as those in face or trunk. Gynaecologists are very often 
the first specialist in visiting these patients with an ulcerative plaque in vulva 
that require confirmation about the type of tumour. It is important to note that 
BCC in vulvar semimucosa can get confused with other neoplasms (malignans 
and benigns ).   
In this work, we describe four vulvar BCCs from three patients. Three of 
these cases are located on the inner aspect of the labia majora, a hairless skin 
area. In these cases, we have also described the expression pattern of different 
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markers by immunohistochemistry.  Based on our data, we discuss about the 
characteristics of these infrequent BCCs.  
 
CASE REPORTS 
In Dermatology Department we have found four cases of genital BCC 
throughout a year. The first case was a 62 years old woman, who consulted for a 
lesion located in the vulva, in the third posterior of the labia majora, near the 
fourchette, that had appeared one year ago. It was an indurated, smooth, 
ulcerated, shiny plaque, that measured 13x9 mm. Histological examination 
showed a superficial BCC. The second case was a woman 66 years old with a 
vulvar lesion that had bled several times for the last two months. It consisted of 
an indurated and eroded plaque of 1.5 cm, located in the inner aspect of the 
labia majora, containing pigmented areas on the periphery (Figure 1a). Once 
removed, the biopsy showed that it was a superficial BCC (Figure 1b).  After 3 
years we review the scar of the previous genital BCC we appreciated a little 
ulcerative plaque next to the previous BCC scar. We took a biopsy of the lesion 
and the result was a superficial BCC.   The third case was an 86 years old 
woman, having a medical history of several facial BCC. She checked for two 
vulvar papulonodules on each sides of the vulva that she had for three months. 
The lesions settled also in the vulvar semimucosa, in the hairless area, and 
measured 0.5 and 0.7 cm in diameter (Figure1c, and not shown). The biopsy 
showed that they were nodular BBC (Figure 1d, and not shown). 
We studied by immunohistochemistry the four vulvar. The antibodies 
(DAKO, Glostrup, Denmark) used were against: CK5/6 (clone D5/16 B4) which 
is expressed in the basal keratinocytes of stratified epithelia; CK7 (clone OV-TL 
12/30) and CK19 (clone RCK108) both present in the simple epithelium with 
5 
 
glandular differentiation such as eccrine and apocrine glands; β-catenin (clone 
β-Catenin-1) as BCC marker; and p63 (DAK-p63) as a stem cell marker. Slides 
were counterstained with hematoxylin. Microscopic analysis was performed by 
two independent observers (M.R.G and F.V.). The degree of expression was 
graded as follows: -, negative; +, weakly positive; ++, strongly positive; +++, 
very strongly positive. The results are shown in Table 1. The four vulvar BCC 
were positive for CK5/6, β-catenin and p63 that are expressed in the majority of 
BCC, but also genital BCC express CK 7 and CK19.  
 
DISCUSSION 
The location of a BCC in the vulvar region is very rare. Until now 300 
cases have only been described. They represent the 0.01-1.75% of BCC and 2-7% 
of vulvar carcinomas (1) and show a more aggressive behaviour given 
thatrecurrences and metastasis are more frequently develop  Currently, nine 
metastatic cases (approximatively, 3,0%) have been published from genital BCC 
(Perrone T, 1987; Hoffman MS, 1988; Winkelmann SE, 1990; Gleeson NC, 
1994; Mizushima J, 1995; Benedet JL, 1997; Feakins RM, 1997; Mulayim N, 
2002; Blok JL, 2012), but considering all the BCC the prevalence of any 
metastatic site is only 0.0028 to 0.55%. This data supports the relevance in the 
study of vulvar BCC.  
In vulvar area we can find other malignancies as Paget's disease. Paget´s 
disease is an uncommon intraepidermal carcinoma where Paget cells are found 
in the histological analysis. Old patients are the mainly affect. Normally the first 
symptom is icth as sometimes happens in vulvar BCC and in the physical 
examination we can find scaly plaques. The origin of Paget´s disease could be 
primary, that means a cutaneous origin. But Paget´s disease also can be 
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secondary, with a origin in a visceral malignancy as in anorectum or colon when 
Paget´s disease appears in anogenital area. Cytokeratin profile could be useful 
to distinguish primary Paget´s disease from the secondary type. Primary 
Paget´s disease usually express CK7 and GCDFP 15 whereas secondary Paget´s 
disease also express CK7, but also CK20. CK 20 is not expressed in primary 
Paget´s disease. Another immunohistochemical differency is  in GCDFP 15 that 
is positive in the primary type and negative en the secondary type ( 
Suthiwartnarueput W. Primary perianal Paget´s disease… J Med Assoc Thai.). 
Trichoblastoma is a  benign tumour, normally appears in neck or in head, 
but a vulvar trichoblastoma has been described in vulvar area recently. The 
histological analysis is  very similar with basal cell carcinoma, so the 
immunohistochemical study can be useful in some cases.  Differential diagnosis 
from basal cell carcinoma can be difficult but is facilitated using 
immunohistochemistry. ( Pina A et al. Vulvar trichoblastoma. J Low Genit Tract 
Dis). Trichoblastoma normally express CK5/6, CK14, CK17, CK19. The 
expression of  CK7, CK8, CK13, CK18, CK20, alpha-smooth-muscle actin is 
normally  negative. Basal cell carcinoma could present in some cases the same 
profile, so  ( Schirren CG et al. Trichoblastoma and BCC… Am J 
Dermatopathol.) the he treatment of trichoblastoma is the excision with 
negative margins.  
 
 The four vulvar  BCCs expressed CK5/6, p63 and β-catenin. The 
expression of p63 and β-catenin is found in many tumours not only skin. 
However all the vulvar BCCs showed expression of CK7 and CK19. Even the 
most accepted theory that explain the origen of BCC located the original cell in 
hair follicle. At the same case that vulvar BCC,  the expression of CK7 and CK19 
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has been observed in different carcinomas derived from the glandular 
epithelium as sebaceous carcinoma, or apocrine glands as extra-mammary 
Paget's disease and multiple adnexal tumours of vulvar location.  
 
 
The most accepted theory about its origin is that BCC results from mutations 
induced by ultraviolet radiation on stem cells from hair follicle and 
mechanosensory niches (3).  It is important to note that three of the vulvar 
BCCs studied in this work were located in non-hairy area (inner aspect of labia 
majora). Then, the epithelium of apocrine or sebaceous glands that are 
abundantly represented in vulvar skin and in hairless semimucosa of labia 
majora may participate on the origin of vulvar BCC. In agreement with this 
hypothesis we have observed high expression of CK7 in the four vulvar BCCs. 
Alessi et al, 2010 described that in nodular BCC the expression of CK7 was not 
frequent but 15 out 17 of BCC with glandular differentiation were CK7 positive. 
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Clinical features from vulvar BCC above and its histological appearence 
immediately below.  
 
Figure 2. 
Case-control comparison: Vulvar BCC on the left, with positivity for CK7 and 
CK19 on the  immunohistochemical study; facial BCC on the right, with 
negativity for CK7 and CK19 on the immunohistochemical study. Both BCC 
correspond at the same patient, who has a large history of BCC.  
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